Bio-Techne Co. (NASDAQ:TECH) Receives $73.44 Consensus Target Price from Brokerages
Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) have been given a consensus rating of “Hold” by the ten ratings firms that are covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price target […]
Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) have been given a consensus rating of “Hold” by the ten ratings firms that are covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price target […]
